Skip to main content

Information on the total number of voting rights and shares of 74Software share capital as of June 30, 2026

Press Release Information on the total number of voting rights and shares of 74Software share capital as of June 30, 2026 Paris, July 2, 2026 – In accordance with Articles L.233-8 II and R.225-73 I of the French Commercial Code (Code de Commerce) and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (RGAMF), 74Software hereby informs its shareholders that, as of June 30, 2026:Total number of shares is 29,746,194. Total number of theoretical voting rights is 41,328,280.It is calculated according to the total number of shares with voting rights, including those whose voting rights have been suspended, and is used to declare threshold crossing by shareholders in accordance with Article 223-11 of the RGAMF.Number of exercisable voting rights is 40,664,803.Disclaimer This document is a translation...

Continue reading

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

ZUG, Switzerland, July 2, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference. The Company will provide an overview and update of its innovative current late-stage portfolio. Key highlights include: Privosegtor, a novel neuroprotective candidate which received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for optic neuritis (ON), in the PIONEER registrational program to address unmet needs for two optic neuropathies targeting...

Continue reading

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th

Demonstrations highlight secure, frictionless authentication delivering substantial ROI for financial institutions AMMAN, Jordan and MADRID, July 02, 2026 (GLOBE NEWSWIRE) — BIO-key International, Inc. (OTCQB: BKYI), a global leader in biometric-powered identity and access management (IAM), will participate in an invitation-only cybersecurity and identity workshop hosted in Amman  by the Association of Banks in Jordan on July 6th. The invitation-only government-sponsored event brings together cybersecurity, IT, digital transformation, and management leaders from leading banks and financial institutions across Jordan to address cyber threats, identity security challenges, modern authentication strategies and IT return-on-investment. Over 25 institutions, including C-level executives, have confirmed attendance. Attendees will learn...

Continue reading

Share Buyback Transaction Details June 25 – July 1, 2026

PRESS RELEASE                                         Share Buyback Transaction Details June 25 – July 1, 2026 Alphen aan den Rijn – July 2, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 110,222 of its own ordinary shares in the period from June 25, 2026, up to and including July 1, 2026, for €6.2 million and at an average share price of €56.24. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

Continue reading

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

ZUG, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference. The Company will provide an overview and update of its innovative current late-stage portfolio. Key highlights include: Privosegtor, a novel neuroprotective candidate which received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for optic neuritis (ON), in the PIONEER registrational program to address unmet needs for...

Continue reading

Peakmedia digital signage GmbH rebrands as ZetaDisplay Austria and appoints Marcel Schramm as Country Director

Team ZetaDisplay AustriaZetaDisplay AustriaZetaDisplay is strengthening its position in the Austrian market with the rebranding of Peakmedia, acquired in 2023, as ZetaDisplay Austria. The transition marks the next phase of integration into the wider ZetaDisplay organisation and is further strengthened by the appointment of Marcel Schramm as Country Director. Since joining the team in Ebbs in Austria, Peakmedia has continued to deliver innovative digital signage solutions across the DACH region and Easten Europe, supporting customers with strategic consulting, software, hardware integration, content and managed services. The rebrand marks the next step in the integration of the Austrian team into ZetaDisplay, uniting its established local presence with the scale, expertise and international capabilities of one of Europe’s...

Continue reading

Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’

Inside My RaceCapgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 1Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 3Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 4Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 2Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Capgemini Press contact: Sereydana Oum+33 6 61 42 03 59Sereydana.oum@capgemini.com Tour de France Press contact:Julien Rozenblum +33 6 40 16 67 67jrozenblum@aso.fr Capgemini and the Tour de France bring fans personalized, AI-powered...

Continue reading

Symbotic Announces Acquisition of ARMS Innovations, Advancing a New Era of Warehouse Operations Optimization

Transaction expands Symbotic’s solution from automation execution to full-scale, AI-powered operational intelligence across the entire warehouse ecosystem Unifies automated systems and human workflows to enable seamless operations in highly complex environments with reduced downtime and improved performance WILMINGTON, Mass., July 02, 2026 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the acquisition of ARMS Innovations Ltd. (ARMS), a UK-based software company specializing in real-time operational intelligence solutions for complex automated warehouse environments. The acquisition marks a significant strategic milestone in Symbotic’s mission to transform supply chain operations by advancing a new industry category: Warehouse Operations Optimization. By...

Continue reading

Telia Lietuva invests EUR 7.1 million to expand 5G and upgrade 500 base stations

During 2026, Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) will invest EUR 7.1 million in expanding its mobile network. The investment will fund the construction of 50 new base stations, the modernisation of 300 existing sites and the upgrade of around 130 additional locations with new radio equipment. The Company is also starting to deploy the 1,500 MHz spectrum acquired in the recent auction, increasing 5G network capacity to support continued growth in mobile data traffic. Mobile data traffic in Lithuania is growing by around 25% annually, one of the fastest growth rates in Europe. Consumers are increasingly using high-definition video streaming, cloud services, artificial intelligence applications and connecting a growing number of smart devices. This consistently increases the load on the network and requires continuous...

Continue reading

Sampo appoints Diane Michelberger Head of Investor Relations

Sampo plc, press release, 2 July 2026 at 9:30 am EEST Sampo appoints Diane Michelberger Head of Investor Relations Diane Michelberger has been appointed Head of Investor Relations for Sampo Group. She will assume her role in early Q4/2026. Michelberger has extensive experience in investor relations within the insurance industry. Since 2023, she has acted as Head of Investor Relations at Admiral Group. Prior to that, she held various positions at Aviva and AXA UK. For further information, please contact: Mirko HurmerintaInterim Head of Investor Relations tel. +358 10 516 0032 Distribution: The principal media www.sampo.com

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.